Patients with myelodysplastic syndromes (MDS) often mobilise abnormal haemopoietic progenitors.

被引：0

作者：

Mijovic, A ^{[1
]}

Howard, J ^{[1
]}

Czepulkowski, B ^{[1
]}

Pagliuca, A ^{[1
]}

Mufti, GJ ^{[1
]}

机构：

[1] Univ London Kings Coll Hosp, London, England

来源：

BONE MARROW TRANSPLANTATION | 1999年 / 23卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

502

引用

页码：S153 / S153

页数：1

共 50 条

[31] Effects of megakaryocyte growth and development factor (MGDF) on in vitro proliferation of megakaryocyte progenitors in myelodysplastic syndromes (MDS) [J].

FontenayRoupie, M ;

Bouscary, D ;

Casadevall, N ;

Botella, A ;

Picard, F ;

Guesnu, M ;

Melle, J ;

Dreyfus, F .

THROMBOSIS AND HAEMOSTASIS, 1997, :P3032-P3032

[32] A Novel Prognostic Model in Heavily Treated Patients with Myelodysplastic Syndromes (MDS) [J].

Nazha, Aziz ;

Seastone, David J. ;

Radivoyevitch, Tomas ;

Gerds, Aaron T. ;

Mukherjee, Sudipto ;

Carraway, Hetty E. ;

Advani, Anjali S. ;

Kalaycio, Matt E. ;

Rupp, Gina ;

Colaluka, Kristin ;

Hobson, Sean ;

Maciejewski, Jaroslaw P. ;

Sekeres, Mikkael A. .

BLOOD, 2014, 124 (21)

[33] A Personalized Prediction Model to Risk Stratify Patients with Myelodysplastic Syndromes (MDS) [J].

Nazha, Aziz ;

Komrokji, Rami S. ;

Barnard, John ;

Al-Issa, Karam ;

Padron, Eric ;

Madanat, Yazan F. ;

Kuzmanovic, Teodora ;

Abuhadra, Nour ;

Steensma, David P. ;

DeZern, Amy E. ;

Roboz, Gail J. ;

Garcia-Manero, Guillermo ;

List, Alan F. ;

Maciejewski, Jaroslaw P. ;

Sekeres, Mikkael A. .

BLOOD, 2017, 130

[34] Levels of circulating endothelial adhesion molecules in patients with myelodysplastic syndromes (MDS). [J].

Sudhoff, T ;

Wehmeier, A ;

Aul, C .

BLOOD, 1997, 90 (10) :4051-4051

[35] MEGAKARYOCYTOPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) WITH AND WITHOUT DEL(5+) [J].

PODOLAKDAWIDZIAK, M ;

GEDDES, D ;

BOWEN, D .

EUROPEAN JOURNAL OF HAEMATOLOGY, 1990, 45 (02) :115-116

[36] COMBINATION OF ORAL RIGOSERTIB AND INJECTABLE AZACITIDINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) [J].

Navada, S. ;

Garcia-Manero, G. ;

Hearn, K. ;

Odchimar-Reissig, R. ;

Demakos, E. ;

Fenaux, P. ;

Petrone, M. ;

Zbyszewski, P. ;

Fruchtman, S. ;

Silverman, L. .

LEUKEMIA RESEARCH, 2017, 55 :S30-S30

[37] Influence of different treatment strategies on the prognosis of patients with myelodysplastic syndromes (MDS) [J].

Nachtkamp, K. ;

Kuendgen, A. ;

Strupp, C. ;

Gattermann, N. ;

Giagounidis, A. ;

Haas, R. ;

Germing, U. .

LEUKEMIA RESEARCH, 2007, 31 :S30-S30

[38] Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes (MDS). [J].

Yazji, S ;

Giles, F ;

Kantarjian, H ;

Estey, E ;

O'Brien, S ;

Kurzrock, R .

BLOOD, 2002, 100 (11) :794A-794A

[39] Iron chelation treatment in patients with myelodysplastic syndromes (MDS): the experience of the Hellenic MDS Study Group [J].

Kouraklis, A. ;

Symeonidis, A. ;

Galanopoulos, A. ;

Kaiafa, G. ;

Tavernarakis, I. ;

Tsirakis, G. ;

Michali, E. ;

Tsaftaridis, P. ;

Loukidis, K. ;

Aggelidis, A. ;

Zoumbos, N. .

LEUKEMIA RESEARCH, 2009, 33 :S119-S120

[40] Genomic imbalances in 139 patients with myelodysplastic syndromes (MDS) and complex karyotypes [J].

Zemanova, Zuzana ;

Michalova, Kyra ;

Brezinova, Jana ;

Buryova, Halka ;

Kostylkova, Karla ;

Bystricka, Dagmar ;

Novakova, Milena ;

Sarova, Iveta ;

Izakova, Silvia ;

Lizcova, Libuse ;

Ransdorfova, Sarka ;

Zmolikova, Jana ;

Siskova, Magda ;

Cermak, Jaroslav .

CHROMOSOME RESEARCH, 2013, 21 :S92-S93

← 1 2 3 4 5 →